Novartis Dividends
| NVS Stock | USD 104.28 0.43 0.41% |
Dividend Paid And Capex Coverage Ratio is likely to gain to 1.95 in 2024, whereas Dividends Paid is likely to drop slightly above 5 B in 2024. Novartis' past performance could be the main factor of why investors trade Novartis AG ADR stock today. Investors should clearly understand every aspect of the Novartis dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Novartis' dividend schedule and payout information. Novartis AG ADR dividends can also provide a clue to the current valuation of Novartis.
Number Of Dividends | Years Issued 25 | Previous Year 1 Times | Current Year 1 Times | Year Average 1 | Volatility 0.0 |
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 7.3 B | 5 B | |
| Dividend Yield | 0.03 | 0.02 | |
| Dividend Payout Ratio | 0.49 | 0.42 | |
| Dividend Paid And Capex Coverage Ratio | 1.44 | 1.95 |
Novartis |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Novartis must own a stock before its ex-dividend date to receive its next dividend.
Novartis Dividends Paid Over Time
Today, most investors in Novartis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Novartis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Novartis dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Novartis Historical Dividend Yield Growth
A solid dividend growth pattern of Novartis could indicate future dividend growth is likely, which can signal long-term profitability for Novartis AG ADR. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is Novartis AG ADR dividend as a percentage of Novartis stock price. Novartis AG ADR dividend yield is a measure of Novartis stock productivity, which can be interpreted as interest rate earned on an Novartis investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Novartis Expected Dividend Income Per Share
Dividend payment represents part of Novartis' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Novartis. Novartis' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$2.36 Bottom Scenario | $2.42 | $2.47 Top Scenario |
One Year
Novartis AG ADR expected dividend income per share adjusted for ongoing price standard deviation
Novartis Past Distributions to stockholders
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.846 | Dividend Share 3.919 | Earnings Share 5.72 | Revenue Per Share 24.543 | Quarterly Revenue Growth 0.089 |
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.